tiprankstipranks
Arrowhead Pharmaceuticals (ARWR)
NASDAQ:ARWR

Arrowhead Pharmaceuticals (ARWR) Cash flow

1,365 Followers

Arrowhead Pharmaceuticals Cash Flow

ARWR's free cash flow for Q1 2024 was $-186.50M. For the 2024 fiscal year, ARWR's free cash flow was decreased by $-141.72M and operating cash flow was $-117.84M. See a summary of the company’s cash flow.
Cash Flow
TTM
Sep 23Sep 22Sep 21Sep 20Sep 19
Operating Cash Flow
$ -196.21M$ -153.89M$ -136.13M$ 171.31M$ -95.39M$ 173.03M
Investing Cash Flow
$ 49.38M$ -96.16M$ -5.42M$ -141.68M$ -240.78M$ -47.75M
Financing Cash Flow
$ 2.74M$ 253.05M$ 65.19M$ 11.30M$ 257.95M$ 66.38M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 411.66M$ 110.90M$ 108.07M$ 184.52M$ 143.58M$ 221.80M
Income Tax Paid Supplemental Data
$ -999.00K-$ -2.00K$ -2.00K-$ 302.40K
Interest Paid Supplemental Data
----$ 0.00$ 27.44K
Issuance Of Capital Stock
----$ 250.48M$ 60.52M
Issuance Of Debt
------
Repayment Of Debt
----$ 0.00$ -2.42M
Free Cash Flow
$ -402.70M$ -330.63M$ -188.91M$ 147.75M$ -107.34M$ 161.03M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Arrowhead Pharmaceuticals Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis